medigraphic.com
ISSN 2992-8036 (Electronic)
ISSN 2306-4102 (Print)
Órgano Oficial del Colegio Mexicano de Ortopedia y Traumatología

2013, Number 5

<< Back Next >>

Acta Ortop Mex 2013; 27 (5)

Heterologous allogeneic blood transfusion as a risk factor associated with the adverse course of the surgical wound in primary hip surgery

Durán-Nah JJ, Cárabes-González JA, Miam-Viana EJ

Language: Spanish
References: 28
Page: 305-311
PDF size: 253.99 Kb.


ABSTRACT

Background: Due to its immunomodulating effects mediated by leukocytes and interleukins, heterologous allogeneic blood transfusion has been considered as a risk factor for both morbidity and mortality in patients undergoing orthopedic surgery, including hip surgery. This research analyzed whether heterologous allogeneic blood transfusion is a risk factor associated with the adverse course or complication of the surgical wound in patients undergoing primary hip surgery due to fracture at a general hospital in 2008-2009. Material and methods: Forty-nine patients who had a complication (cases) and 207 with no complications (controls) were identified and both groups were compared with a bivariate and multivariate analysis, and demographic and clinical data, including having undergone blood transfusion or not. Results: Not having received a blood transfusion was identified as a variable that reduced the risk of surgical wound complications (OR = 0.05, 95% confidence interval [CI 95%] 0.0067 to 0.16; χ2 with p ‹ 0.001). The multivariate model excluded as clinically significant variables the duration of surgery (OR = 1.01, CI 95% 0.99 to 1.02; p = 0.12) and certain chronic conditions (OR = 0.54, CI 95% 0.13 to 2.24 for diabetes mellitus, OR = 1.16, CI 95% 0.29 to 4.60 for chronic hypertension, OR = 1.21, CI 95% 0.19 to 7.51 for various heart diseases). Conclusions: Not having received a blood transfusion reduced 95% the risk of surgical wound complications. Neither the duration of surgery nor a specific comorbid condition were associated with the former event.


REFERENCES

  1. Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch EB: An analysis of blood management in patients having a total hip o knee arthroplasty. J Bone J Surg. 1999; 81: 2-10.

  2. Weber EWG, Slappendel R, Prins MH, van der Schaaf DB, Durieux ME, Stümper D: Perioperative blood transfusion and delayed wound healing after hip replacement surgery: effects on duration of hospitalization. Anesth Analg. 2005; 100: 1416-21.

  3. Pola E, Papaleo P, Santoliquido A, Gasparini G, Aulisa L, De Santis L: Clinical factors associated with an increased risk of perioperative blood transfusion in nonanemic patients undergoing total hip arthroplasty. J Bone Joint Surg (Am). 2004; 86: 57-61.

  4. Salido JA, Marin LA, Gómez LA, Zorilla P, Martínez C: Preoperative hemoglobin levels and the need for transfusion after prosthetic hip and knee surgery. J Bone Joint Surg (Am). 2002; 84: 216-20.

  5. Pierson JL, Hannon TJ, Earles DR: A Blood-conservation algorithm to reduce blood transfusions after total hip and knee arthroplasty. J Bone Joint Surg. 2004; 86A: 512-18.

  6. Cuenca-Espiérrez J, García-Arce JA, Martínez-Martín AA, Solano VM, Herrera-Rodríguez A: Infección postquirúrgica en las fracturas de cadera: la transfusión y su efecto inmunomodulador. Rev Esp Cir Osteoart. 2003; 38: 151-6.

  7. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP: Transfusion medicine. N Engl J Med. 1999; 340: 438-47.

  8. Borghi B, Casati A: incidence and risk factors for allogeneic blood transfusion during major joint replacement using an integrated autotransfusion regimen. The Rizzoli study group on orthopaedic anaesthesia. Eur J Anaesthesiol. 2000; 17: 411-7.

  9. Rovera F, Dionigi G, Boni L, Imperatori A, Tabacchi A, Carcano G, et al: Postoperative infection after oesophageal resections: the role of blood transfusions. WJSO [serie en Internet]. 2006; 4(80): 6.

  10. Glance LG, Dick AW, Mukamel DB, Fleming FJ, Zollo RA, Wissler R, et al: Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing non-cardiac surgery. Anesthesiology. 2011; 114: 283-92.

  11. Johnston P, Wynn-Jones H, Chakravarty D, Boyle A, Parker MJ: Is perioperative blood transfusion a risk factor for mortality of infection after hip fracture? J Orthop Trauma. 2006; 20: 675-9.

  12. Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, et al: Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med. 2011; 365: 2453-62.

  13. Uçkay I, Agostinho A, Belaieff W, Toutous-Trellu L, Scherer-Pietramaggiori S, Andres A, et al: Noninfectious wound complications in clean surgery: Epidemiology, risk factors, and association with antibiotic use. World Journal of Surgery. 2011; 35: 973-80.

  14. Zuckerman JD: Hip fracture. N Engl J Med 1996; 334: 1519-25.

  15. Steinitz D, Harvey EJ, Leighton RK, Petrie DP: Is homologous blood transfusion a risk factor for infection after hip replacement? Can J Surg. 2001; 44: 355-8.

  16. Rashiq S, Shah M, Chow AK, O’Connor PJ, Finegan BA: Predicting allogeneic blood transfusion use in total joint arthroplasty. Anesth Analg. 2004; 99: 1239-44.

  17. Couvret C, Tricoche S, Baud A, Dabo B, Buchet S, Palud M, et al: The reduction of preoperative autologous blood donation for primary total hip or knee arthroplasty: the effect on subsequent transfusion rate. Analg Anesth. 2002; 94: 815-23.

  18. American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies: Practice guidelines for perioperative blood transfusion and adjuvant therapies. Anesthesiology. 2006; 105: 198-208.

  19. Pedersen AB, Mehnert F, Overgaard S, Johnsen SP: Allogeneic blood transfusion and prognosis following total hip replacement: a population-based follow-up study. BMC Musculoskeletal Disorders [serie en Internet]. 2009; 10(167): 12.

  20. Patel VP, Walsh M, Sehgal B, Preston C, DeWal H, Di Cesare PE: Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty. J Bone Joint Surg Am. 2007; 89: 33-38.

  21. Chadha VK. Sample size determination in health studies. NTI Bulletin. 2006; 42: 55-62.

  22. du Prel JB, Hommel G, Röhrig B, Blettner M: Confidence interval or p-value? Dtsch Arztebl Int. 2009; 106: 335-9.

  23. Carson JL, Duff A, Berlin JA, Lawrence VA, Poses RM, Huber EC, et al: Perioperative blood transfusion and postoperative mortality. JAMA. 1998; 279: 199-205.

  24. Tang R, Chen HH, Wang YL, Changchein CR, Chen JS, Hsu KC, et al: Risk factors for surgical site infection after elective resection of the colon and rectum: a single-center perspective study of 2,809 consecutive patients. Ann Surg. 2001; 234: 181-9.

  25. Vamvakas E, Blajchman MA: Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? Blood. 2001; 97: 1180-95.

  26. Marcucci C, Madjdpour C, Spahn DR: Allogeneic blood transfusions: benefit, risks and clinical indications in countries with a low or high human development index. Br Med Bull. 2004; 70: 15-28.

  27. Ertel W, Keel M, Neidthardt R, et al: Inhibition of the defense system stimulating interleukin-12 interferon-gamma pathway during critical illness. Blood. 1997; 89: 1612-20.

  28. van Hilten JA, van dewatering LMG, van Bockel JH, van de Velde CJH, Kievit J, Brand R, et al: Effects of transfusion with red cells filtered to remove leucocytes: randomized controlled trial in patients undergoing major surgery. BMJ. 2004; 328: 1281-4.




2020     |     www.medigraphic.com